Argus downgraded Zoetis Inc. (NYSE:ZTS) to Hold from Buy, citing increased competition and shifting demand in the animal health market.
The company faces margin compression and missed Wall Street expectations.
Zoetis shares have fallen 51% over the past year, trading at $80.23.
Argus noted that top pipeline products compete with existing portfolio, potentially cannibalizing sales.
9 analysts have revised earnings downwards for the upcoming period.
Despite challenges, InvestingPro analysis suggests the stock appears undervalued.
Bond.az reports Zoetis recently declared a quarterly dividend of $0.53 per share.
